| Oct 31 |
Syros Pharmaceuticals GAAP EPS of -$0.16 beats by $0.52
|
| Oct 31 |
Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update
|
| Oct 30 |
Syros Pharmaceuticals Q3 2024 Earnings Preview
|
| Oct 24 |
Syros to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
|
| Oct 9 |
Syros Pharmaceuticals Inc (SYRS) Q2 2024 Earnings Call Highlights: Strategic Focus on ...
|
| Sep 14 |
Insider Spends US$161k Buying More Shares In Syros Pharmaceuticals
|
| Sep 12 |
Insider Buying: CFO Jason Haas Acquires 100,000 Shares of Syros Pharmaceuticals Inc (SYRS)
|
| Sep 12 |
Insider Buying: President & CEO Conley Chee Acquires Shares of Syros Pharmaceuticals Inc (SYRS)
|
| Aug 27 |
Syros Pharmaceuticals to Present at Upcoming Medical and Investor Conferences
|
| Aug 14 |
Syros (SYRS) Falls 62% on Phase II Leukemia Study Termination
|
